Campaign seeks to counter influence of pharma sales reps

NewsGuard 100/100 Score

The Boston Globe on Monday examined the Independent Drug Service project, a $1 million campaign in Pennsylvania that sends consultants to inform physicians about the effectiveness of different medications based on scientific evidence to "combat the sales pitches" of pharmaceutical companies.

According to the Globe, pharmaceutical company sales representatives, who visit physicians to increase the number of prescriptions that physicians write for their medications, often "wrongly hype expensive new drugs when older, cheaper treatments work just as well."

The campaign, sponsored by the Pennsylvania Department of Aging and administered by Brigham and Women's Hospital in Boston, includes a team of 10 consultants who have made about 1,200 visits to about 500 physicians in the state.

In addition, the campaign includes about six internists and Harvard Medical School instructors who provide talking points that physicians can use to discuss medications with patients.

Jerome Avorn, a Harvard Medical School professor and a leader of the campaign, said that the effort could expand to other states later this year (Henderson, Boston Globe, 2/26).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common HIV drugs linked to reduced Alzheimer's disease risk